The Need for a Prophylactic Gastrojejunostomy for Unresectable Periampullary Cancer - A Prospective Randomized Multicenter Trial With Special Focus on Assessment of Quality of Life
Executive Summary
This briefing document synthesizes the findings of a prospective randomized multicenter trial conducted to determine the efficacy of a prophylactic gastrojejunostomy (double bypass) in patients with unresectable periampullary cancer discovered during exploratory surgery. The study compares a single bypass (hepaticojejunostomy) against a double bypass (hepaticojejunostomy and gastrojejunostomy).
The trial concludes that a prophylactic gastrojejunostomy significantly reduces the incidence of late gastric outlet obstruction (GOO) and the necessity for subsequent reoperations without increasing postoperative morbidity or mortality. Key statistical takeaways include:
GOO Incidence: 5.5% in the double bypass group compared to 41.4% in the single bypass group.
Reoperation Rate: Only 2.8% of double bypass patients required a reoperation for GOO, versus 20.7% in the single bypass group.
Risk Reduction: The absolute risk reduction for reoperation was 18%, with a "number needed to treat" (NNT) of 6.
Quality of Life (QoL): No significant differences were found between treatment groups regarding health-related quality of life.
Based on these findings and their alignment with previous research, the trial was terminated early, as the evidence strongly supports making double bypass the standard surgical palliative treatment for this patient population.
Clinical Context and Objective
Periampullary tumors include pancreatic, bile duct, and ampullary carcinomas. Between 25% and 75% of patients who undergo exploratory surgery with the intent of resection (pancreaticoduodenectomy) are found to have unresectable disease due to local vascular invasion or metastases.
The primary palliative goals for these patients are the relief of obstructive jaundice, duodenal obstruction, and pain. While biliary drainage (single bypass) is standard, the necessity of a prophylactic gastrojejunostomy to prevent future duodenal obstruction has been a subject of surgical controversy. Critics have historically cited concerns regarding increased postoperative complications, such as delayed gastric emptying (DGE) and longer hospital stays.
Study Objectives
Primary Endpoints: Incidence of clinical gastric outlet obstruction and the need for surgical intervention.
Secondary Endpoints: Postoperative morbidity, mortality, hospital stay duration, survival rates, and health-related Quality of Life (QoL).
Methodology and Trial Design
The trial was a prospective randomized multicenter study involving four centers in the Netherlands (two academic and two general hospitals) between December 1998 and March 2002.
Participants: 65 patients with unresectable periampullary cancer found during surgery.
Randomization: Patients were stratified by center and the presence of metastases.
Double Bypass (n=36): Received a hepaticojejunostomy and a retrocolic gastrojejunostomy.
Single Bypass (n=29): Received only a hepaticojejunostomy.
Interim Analysis: Planned at 50% inclusion (70 patients) following the publication of a similar study by the Johns Hopkins group.
Exclusions: History of upper GI surgery, endoscopic treatment >3 months, or existing gastric/duodenal obstruction.
Comparative Analysis of Clinical Outcomes
The following table summarizes the short-term and long-term results of the two surgical approaches:
Primary Findings: Gastric Outlet Obstruction
The incidence of late GOO was drastically higher in patients who received only a biliary bypass. Over 40% of the single bypass group developed obstruction symptoms, and one in five required a second major surgery. In contrast, the prophylactic gastrojejunostomy nearly eliminated the need for re-intervention.
Postoperative Morbidity and Recovery
Delayed Gastric Emptying (DGE): While DGE was more frequent in the double bypass group (17% vs. 3%), the difference was not statistically significant.
Hospital Stay: Patients receiving the double bypass stayed a median of 2 days longer, which the study notes as a marginal, non-significant increase (P = 0.06).
Complications: Rates of biliary or gastrojejunal anastomotic leaks were identical between groups.
Quality of Life (QoL) Assessment
A significant component of this trial was the prospective measurement of QoL using the EORTC QLQ-C30 and Pan26 questionnaires. This addressed a gap in prior research (specifically the Hopkins trial) regarding the patient perspective.
Postoperative Trends: Both groups experienced a significant temporary decrease in functional scales (except physical functioning) and an increase in pain/digestive symptoms immediately after surgery.
Recovery: Most QoL scores returned to baseline within four months post-surgery.
Treatment Comparison: There were no significant differences in global health status, emotional functioning, or digestive symptoms between the single and double bypass groups at any point during follow-up.
Terminal Phase: In the two months prior to death, both groups showed a rapid, identical decline in global health and emotional functioning.
Discussion and Institutional Insights
Rationale for Early Termination
The trial was discontinued after the interim analysis because the primary endpoint (reduction of GOO) reached high statistical significance, mirroring the results of a contemporary randomized trial from Johns Hopkins. Researchers concluded that continuing the study would be unjustifiable as the benefit of double bypass was sufficiently proven.
Expert Commentary and Generalizability
Center Effect: The trial’s multicenter nature, including general hospitals, suggests the results can be generalized beyond "centers of excellence."
Functional vs. Organic Obstruction: Discussion among surgeons noted that GOO may sometimes be functional rather than organic, but the study emphasized that functional outcome is the most important metric for palliative care.
Surgical Standardization: The procedures were standardized across all participating centers, including routine chemical splanchnicectomy for pain management.
Key Conclusions
The study confirms that in patients with unresectable periampullary cancer:
Double bypass is superior to single bypass for preventing late GOO and avoiding the trauma of reoperation.
Safety Profile: Adding a gastrojejunostomy does not significantly increase mortality or major morbidity.
Patient Wellbeing: The additional procedure does not negatively impact long-term Quality of Life compared to a single bypass.
The authors state that this study provides "sufficient evidence" to mandate a double bypass consisting of a hepaticojejunostomy and prophylactic gastrojejunostomy as the preferred surgical palliative strategy.
